Literature DB >> 12146770

Healing of Achilles tendon, an experimental study: part 2--Histological, immunohistological and ultrasonographic analysis.

H Thermann1, O Frerichs, M Holch, A Biewener.   

Abstract

In 105 rabbits the course of healing was examined at one, two, four, eight and 12 weeks (21 rabbits per group) after an experimental Achilles tendon rupture. The following treatment modalities were compared: A) primary functional treatment; B) operative functional treatment (resorbable suture); and C) operative functional treatment with fibrin glue. For the functional (after)-treatment a special orthosis was applied. A 7.5 MHz Ultrasound probe was used for ultrasonographic evaluation. The histological specimens were stained in Masson-Goldner and Azan technique. Collagen Type III was depicted immunhistologically. A semiquantitative fibrocyte count was performed. The histological results showed a smooth healing in the primary functional treatment group (A), reaching parallel orientation of collagen fibers at 12 weeks. In the suture group (B), a secondary gapping of the tendon stumps was detectable after one week as in all other groups. In the fibrin group (C), the fibrin was resorbed after four weeks without essential influence to the course of healing. At 12 weeks the histological evaluation in all groups showed approximately normal tendon pattern. Immunohistochemically, all groups showed cell-associated positive reactions for type-III collagen after one week with a maximum after two weeks. The semiquantitative fibrocyte count in the primary functional group showed a maximal number after one week. In the fibrin glue and suture groups the maximal number could be found after two weeks. Sonographically an increase in tendon thickness was detectable up to the fourth week in all groups. The secondary gapping of the tendon stumps in the suture group could also be detected sonographically. The echogenicity of the tendon during the course of healing showed increasing homogeneity and parallelism in all groups. At 12 weeks the echogenicity was comparable in all groups. The experiment suggests the equivalence of primary functional treatment to a combination of operative and functional therapy in Achilles tendon rupture.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12146770     DOI: 10.1177/107110070202300704

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  6 in total

1.  The effect of corticosteroid on collagen expression in injured rotator cuff tendon.

Authors:  Anthony S Wei; John J Callaci; Dainius Juknelis; Guido Marra; Pietro Tonino; Kevin B Freedman; Frederick H Wezeman
Journal:  J Bone Joint Surg Am       Date:  2006-06       Impact factor: 5.284

Review 2.  A review on animal models and treatments for the reconstruction of Achilles and flexor tendons.

Authors:  Marta Bottagisio; Arianna B Lovati
Journal:  J Mater Sci Mater Med       Date:  2017-02-02       Impact factor: 3.896

3.  Temporal healing in rat achilles tendon: ultrasound correlations.

Authors:  Connie S Chamberlain; Sarah E Duenwald-Kuehl; Gregory Okotie; Sabrina H Brounts; Geoffrey S Baer; Ray Vanderby
Journal:  Ann Biomed Eng       Date:  2012-11-13       Impact factor: 3.934

4.  Healing of human Achilles tendon ruptures: radiodensity reflects mechanical properties.

Authors:  Thorsten Schepull; Per Aspenberg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-10-27       Impact factor: 4.342

5.  Three-year results from a preclinical implantation study of a long-term resorbable surgical mesh with time-dependent mechanical characteristics.

Authors:  H Hjort; T Mathisen; A Alves; G Clermont; J P Boutrand
Journal:  Hernia       Date:  2011-10-05       Impact factor: 4.739

6.  Mechanical properties during healing of Achilles tendon ruptures to predict final outcome: a pilot Roentgen stereophotogrammetric analysis in 10 patients.

Authors:  Thorsten Schepull; Joanna Kvist; Christer Andersson; Per Aspenberg
Journal:  BMC Musculoskelet Disord       Date:  2007-11-26       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.